ASBPW

Aspire Biopharma Holdings, Inc. Warrant

34 hedge funds and large institutions have $536K invested in Aspire Biopharma Holdings, Inc. Warrant in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
-1
Holders Change %
-2.86%
% of All Funds
0.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
Closed
4
Calls
$714K
Puts
Net Calls
+$714K
Net Calls Change
-$1.5M
Name Holding Trade Value Shares
Change
Shares
Change %
AC
1
Athos Capital
Hong Kong
$236K
PC
2
Periscope Capital
Ontario, Canada
$44K
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$31.6K
LA
4
Linden Advisors
New York
$30.5K
SCM
5
Saba Capital Management
New York
$29.6K
HCM
6
Highbridge Capital Management
New York
$25.5K -$45K
AA
7
AQR Arbitrage
Connecticut
$19.5K
SC
8
Sculptor Capital
New York
$17.3K
Verition Fund Management
9
Verition Fund Management
Connecticut
$13K
WAM
10
Wolverine Asset Management
Illinois
$12.1K
Barclays
11
Barclays
United Kingdom
$11K
TCA
12
Taconic Capital Advisors
New York
$9.03K
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$6.02K
CCM
14
Context Capital Management
California
$5.27K
Nomura Holdings
15
Nomura Holdings
Japan
$4.5K
PAMP
16
Polar Asset Management Partners
Ontario, Canada
$4.17K
EAM
17
Exos Asset Management
New York
$4.12K +$4.12K +137,000 New
WA
18
Whitebox Advisors
Minnesota
$3.76K
LP
19
LMR Partners
United Kingdom
$3.76K
FSI
20
Flow State Investments
Illinois
$3.42K +$406 +13,498 +13%
CSD
21
Clear Street Derivatives
New York
$3.19K +$3.19K +106,000 New
JPMorgan Chase & Co
22
JPMorgan Chase & Co
New York
$3.01K -$6K
KL
23
KIM LLC
Kansas
$3.01K
CCM
24
CAAS Capital Management
New York
$2.26K
CS
25
Clear Street
New York
$1.6K